Loading
Assoc. Prof. Chingching Fucharoen

Assoc. Prof. Chingching Fucharoen

Department of Medicine,
Faculty of Medicine,
Khon Kaen University
14044989400: H-INDEX 18

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI
Created with Highcharts 4.0.4SCOPUSPUBMEDISITCI

TitleAuthorYearSCOPUSPUBMEDISITCI
1. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Heijnen, IA
Foocharoen, C
Bannert, B
Carreira, PE
Caporali, R
Smith, V
Kumánovics, G
Becker, MO
Vanthuyne, M
Simsek, I
Bocelli-Tyndall, C
Walker, UA
0
2. GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis. Chunlertrith, K
Noiprasit, A
Foocharoen, C
Mairiang, P
Sukeepaisarnjaroen, W
Sangchan, A
Sawadpanitch, K
0
3. Interesting case anaphylaxis after intra-articular steroid injection in out patient department : review literature Chingching Foocharoen
Siraphop Suwannaroj
2004
4. Estimated volumetric bone mineral density in a rural Thai men and women: Khon Kaen Osteoporosis Study (KKOS). Pongchaiyakul, C.
Nguyen, T.V.
Foocharoen, C.
Rajatanavin, R.
2005
5. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus Foocharoen, C
Tiamkao, S
Srinakarin, J
Chamadol, N
Sawanyawisuth, K
2006
6. D-dimer and pulmonary arterial hypertension in systemic sclerosis. Kiatchoosakun, S.
Ungkasekvinai, W.
Tatsanavivat, P.
Foocharoen, C.
Suwannaroj, S.
Nanagara, R.
2007
7. Rheumatic Syndrome in Elderly Due to Treatment Chingching Foocharoen 2008
8. The best criteria to diagnose metabolic syndrome in hypertensive Thai patients Limpawattana, P
Sawanyawisuth, K
Busaracome, P
Foocharoen, C
Phitsanuwong, C
Chumjan, S
Chotmongkol, R
Chaisuksant, S
2008
9. Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): A study at srinagarind hospital Foocharoen, C
Nanagara, R
Salang, L
Suwannaroj, S
Mahakkanukrauh, A
2009
10. CLINICAL FEATURES OF TUBERCULOUS SEPTIC ARTHRITIS IN KHON KAEN, THAILAND A 10-YEAR RETROSPECTIVE STUDY Foocharoen, C.
Nanagara, R.
Suwannaroj, S.
Mahakkanukrauh, A.
2010
11. Circulating Mitochondrial DNA Copy Numbers As a Disease and Activity Marker in ANCA-Associated Vasculitis Ulrich A. Walker
Nora M. Effelsberg
Nils Venhoff
Chingching Foocharoen
Jens Thiel
Paul Hasler
Dirk Lebrecht
2011
12. Circulating Mitochondrial DNA Copy Numbers As a Highly Sensitive Diagnostic Marker of Systemic Lupus Erythematosus and An Independent Predictor of SLE Activity Nils Venhoff
Jens Thiel
Dirk Lebrecht
Chingching Foocharoen
Nora M. Effelsberg
Marten Trendelenburg
Paul Hasler
Reinhard E. Voll
Ulrich A. Walker
2011
13. Clinical features and disease outcomes of undifferentiated arthritis in Thailand. Foocharoen, C.
Nanagara, R.
Suwannaroj, S.
Mahakkanukrauh, A.
2011
14. Erratum: Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients (Clin Rheumatol (2011) 30 (1263) DOI 10.1007/s10067-011-1744-z) Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2011
15. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. Chingching Foocharoen
Ratanavadee Nanagara
Songsak Kiatchoosakun
Siraphop Suwannaroj
Ajanee Mahakkanukrauh
2011
16. Spontaneous pneumothorax from cryptococcal pneumonia in systemic sclerosis: A case report Sripavatakul, K
Foocharoen, C
2011
17. Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients Foocharoen, C
Mahakkanukrauh, A
Suwannaroj, S
Nanagara, R
2011
18. Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment Foocharoen, C.
Nanagara, R.
Suwannaroj, S.
Mahakkanukrauh, A.
2011
19. Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis. Chingching Foocharoen
Chatchawal Sarntipipattana
Thanit Foocharoen
Ajanee Mahakkanukrauh
Anucha Paupairoj
Yaovalak Teerajetgul
Ratanavadee Nanagara
2011
20. Systemic Sclerosis for General Practitioner Chingching Foocharoen 2011
21. Characteristics, treatments and outcome of psychosis in Thai SLE patients Paholpak, P
Rangseekajee, P
Foocharoen, C
2012
22. Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database. C. Foocharoen
O. Distler
M. Becker
U. Mueller-Ladner
C. von Muehlen
N. Leuchten
U. A. Walker
2012
23. Clinical features and predictive factors in neuropsychiatric lupus Chiewthanakul, P.
Sawanyawisuth, K.
Foocharoen, C.
Tiamkao, S.
2012
24. Clinical features and predictive factors in neuropsychiatric lupus (vol 30, pg 55, 2012) Piyawan Chiewthanakul
Kittisak Sawanyawisuth
Chingching Foocharoen
Somsak Tiamkao
2012
25. Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: A study of the EULAR Scleroderma Trial and Research group Chingching Foocharoen
Alan Tyndall
Eric Hachulla
Edoardo Rosato
Yannick Allanore
Dominique Farge-Bancel
Paola Caramaschi
Paolo Airo
Starovojtova M. Nikolaevna
Jose Antonio Pereira da Silva
Bojana Stamenkovic
Gabriela Riemekasten
Simona Rednic
Jean Sibilia
Piotr Wiland
Ingo Tarner
Vanessa Smith
Anna T. Onken
Walid Ahmed Abdel Atty Mohamed
Oliver Distler
Jadranka Morovic-Vergles
Andrea Himsel
Paloma Garcia de la Pena Lefebvre
Thomas Huegle
Ulrich A. Walker
2012
26. INCIDENCE RATE AND CAUSES OF INFECTION IN THAI SSc PATIENTS C. Foocharoen
Y. Siriphanon
A. Mahakkanukrauh
S. Suwannaroj
R. Nanagara
2012
27. Incidence rate and causes of infection in Thai systemic sclerosis patients. Foocharoen, C.
Siriphannon, Y.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2012
28. Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients. Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2012
29. Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients Wichak Kunyakham
Chingching Foocharoen
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Ratanavadee Nanagara
2012
30. PROGNOSTIC FACTORS OF MORTALITY AND 2-YEAR SURVIVAL ANALYSIS OF SSc WITH PULMONARY ARTERIAL HYPERTENSION IN THAILAND C. Foocharoen
R. Nanagara
S. Kiatchoosakun
S. Suwannaroj
A. Mahakkanukrauh
2012
31. SPONTANEOUS SKIN REGRESSION AND PREDICTORS OF SKIN REGRESSION IN THAI SCLERODERMA PATIENTS C. Foocharoen
A. Mahakkanukrauh
S. Suwannaroj
R. Nanagara
2012
32. Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. Foocharoen, C.
Thavornpitak, Y.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2013
33. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: A EUSTAR group-based study I. A. F. M. Heijnen
C. Foocharoen
B. Bannert
P. E. Carreira
R. Caporali
V. Smith
G. Kumanovics
M. O. Becker
M. Vanthuyne
I. Simsek
C. Bocelli-Tyndall
U. A. Walker
2013
34. Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database Mahakkanukrauh, A
Thavornpitak, Y
Foocharoen, C
Suwannaroj, S
Nanagara, R
2013
35. Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis Netwijitpan, S.
Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2013
36. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients Kitchongcharoenying, P
Foocharoen, C
Mahakkanukrauh, A
Suwannaroj, S
Nanagara, R
2013
37. Aspiration of the elbow joint for treating radial head fractures Thanit Foocharoen
Chingching Foocharoen
Malinee Laopaiboon
Thavatchai Tiamklang
2014
38. ASYMPTOMATIC CARDIAC INVOLVEMENT IN THAI SYSTEMIC SCLEROSIS: PREVALENCE AND CLINICAL CORRELATION C. Foocharoen
B. Pussadhamma
A. Mahakkanukrauh
S. Suwannaroj
R. Nanagara
2014
39. Clinical characteristics and mortality in systemic sclerosis: A comparison between early- and late-referred diseases Foocharoen, C
Mahakkanukrauh, A
Suwannaroj, S
Nanagara, R
2014
40. GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis K. Chunlertrith
A. Noiprasit
C. Foocharoen
P. Mairiang
W. Sukeepaisarnjaroen
A. Sangchan
K. Sawadpanitch
2014
41. Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary? Chingching Foocharoen
Ajanee Mahakkanukrauh
Burabha Pussadhamma
Sittichai Netwijitpan
Siraphop Suwannaroj
Ratanavadee Nanagara
2014
42. Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis Foocharoen, C.
Rosato, E.
2014
43. Prevalence and causes of loss to follow-up among patients with systemic sclerosis. Foocharoen, C.
Yenrom, P.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2014
44. Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis. Amiq Gazdhar
Dirk Lebrecht
Michael Roth
Michael Tamm
Nils Venhoff
Chingching Foocharoen
Thomas Geiser
Ulrich A. Walker
2014
45. Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). Chingching Foocharoen
Burabha Pussadhamma
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Ratanavadee Nanagara
2015
46. Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
Netwijitpan, S.
Nanagara, R.
2015
47. Inter-and intra-observer reliability of modified rodnan skin score assessment in Thai systemic sclerosis patients: A validation for multicenter scleroderma cohort study Foocharoen, C.
Thinkhamrop, B.
Mahakkanukrauh, A.
Suwannaroj, S.
Netwijitpan, S.
Towiwat, P.
Nanagara, R.
2015
48. Asymptomatic cardiac involvement in Thai systemic sclerosis: Prevalence and clinical correlations withn non-cardiac manifestations (preliminary report) Foocharoen, C.
Pussadhamma, B.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2016
49. Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma Chingching Foocharoen
Sittichai Netwijitpan
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Ratanavadee Nanagara
2016
50. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I Chingching Foocharoen
Prangsuporn Suwannachat
Sittichai Netwijitpan
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Ratanavadee Nanagara
2016
51. Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma. Patcharawan Suebmee
Chingching Foocharoen
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Daris Theerakulpisut
Ratanavadee Nanagara
2016
52. Self-assessment of skin tightness severity by scleroderma patients. Kittikorn Daungkum
Chingching Foocharoen
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Bandit Thinkhamrop
Ratanavadee Nanagara
2016
53. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: Randomized placebo-controlled trial Foocharoen, C
Chunlertrith, K
Mairiang, P
Mahakkanukrauh, A
Suwannaroj, S
Namvijit, S
Wantha, O
Nanagara, R
2017
54. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association ,
,
,
Katchamart, W
Narongroeknawin, P
Chevaisrakul, P
Dechanuwong, P
Mahakkanukrauh, A
Kasitanon, N
Pakchotanon, R
Sumethkul, K
Ueareewongsa, P
Ukritchon, S
Bhurihirun, T
Duangkum, K
Intapiboon, P
Intongkam, S
Jangsombatsiri, W
Jatuworapruk, K
Kositpesat, N
Leungroongroj, P
Lomarat, W
Petcharat, C
Sittivutworapant, S
Suebmee, P
Tantayakom, P
Tipsing, W
Asavatanabodee, P
Chiowchanwisawakit, P
Foocharoen, C
Koolvisoot, A
Louthrenoo, W
Siripaitoon, B
Totemchokchyakarn, K
Kitumnuaypong, T
,
2017
55. Phototherapy in systemic sclerosis: Review Chaowattanapanit, S
Choonhakarn, C
Foocharoen, C
Julanon, N
2017
56. Relationship between Peripheral Arterial Stiffness and Estimated Pulmonary Pressure by Echocardiography in Systemic Sclerosis. Burabha Pussadhamma
Wannipa Suwannakrua
Panorkwan Toparkngarm
Chaiyasith Wongvipaporn
Chingching Foocharoen
Ratanavadee Nanagara
2017
57. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais Foocharoen, C
Watcharenwong, P
Netwijitpan, S
Mahakkanukrauh, A
Suwannaroj, S
Nanagara, R
2017
58. Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. Sirithanaphol, W
Sangkhamanon, S
Netwijitpan, S
Foocharoen, C
2018
59. Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis. Foocharoen, C.
Netwijitpan, S.
Mahakkanukrauh, A.
Suwannaroj, S.
Limpawattana, P.
Nanagara, R.
2018
60. Disease modifying anti-rheumatic drugs [dmards] used and treatment outcome of rheumatoid arthritis in rheumatology clinic, Srinagarind Hospital Nanagara, R.
Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
2018
61. Outcome of pregnancy in systemic sclerosis Salang, L.
Buppasiri, P.
Foocharoen, C.
2018
62. Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients Siriphannon, Y.
Foocharoen, C.
Anutrakulchai, S.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2018
63. Pulmonary manifestation in systemic sclerosis in Srinagarind Hospital Mahakkanukrauh, A.
Foocharoen, C.
Suwannaroj, S.
Nanagara, R.
Tumsatan, P.
2018
64. The effect of 4 milligrams intravenous zoledronic acid once yearly on bone mineral density and biochemical bone markers in systemic sclerosis patients with osteoporosis Mahakkanukrauh, A.
Foocharoen, C.
Suwannaroj, S.
Pongchaiyakul, C.
Nanagara, R.
2018
65. The effects of bosentan on the survival, safety, and tolerability in pulmonary hypertension as related to diffuse cutaneous systemic sclerosis Mahakkanukrauh, A.
Foocharoen, C.
Suwannaroj, S.
Kiatchoosakun, S.
Wantha, O.
Nanagara, R.
2018
66. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
Pussadhamma, B.
Chaosuwannakit, N.
2019
67. Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database Foocharoen, C.
Mahakkanukrauh, A.
Suwannaroj, S.
2019
68. Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients Sawadpanich, K
Soison, P
Chunlertrith, K
Mairiang, P
Sukeepaisarnjaroen, W
Sangchan, A
Suttichaimongkol, T
Foocharoen, C
2019
69. PREVALENCE OF PERIPHERAL EOSINOPHILIA AND CLINICAL ASSOCIATIONS IN THAI SYSTEMIC SCLEROSIS PATIENTS Chingching Foocharoen
Patnarin Kongkulkiat
Ajanee Mahakkanukrauh
Pewpan Maleewong Intapan
Wanchai Maleewong
Amonrat Jumnainsong
Nattiya Teawtrakul
Siraphop Suwannaroj
Ratanavadee Nanagara
2019
70. Renal pathology and clinical associations in systemic sclerosis: a historical cohort study. Pantipa Tonsawan
Komkid Talabthong
Anucha Puapairoj
Chingching Foocharoen
2019
71. TUBERCULIN SKIN TEST FOR DETECTION OF TUBERCULOSIS IN SYSTEMIC SCLEROSIS Apichat So-Ngern
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Ratanavadee Nanagara
Chingching Foocharoen
2019
72. Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis Wongjirattikarn, R
Chaowattanapanit, S
Choonhakarn, C
So-Ngern, A
Mahakkanukrauh, A
Foocharoen, C
2020
73. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study Chingching Foocharoen
Kitti Chunlertrith
Pisaln Mairiang
Ajanee Mahakkanukrauh
Siraphop Suwannaroj
Suwassa Namvijit
Orathai Wantha
Ratanavadee Nanagara
2020
Count5549513

JavaScript chart by amCharts 3.20.7

Title Authors NRIIS type Year NRIIS Scholarship

AUTOIMMUNE DISEASEMORTALITYMODIFIED RODNAN SKIN SCOREPULMONARY ARTERIAL HYPERTENSIONPULMONARY HYPERTENSIONSEPTIC ARTHRITISPATHOGENESISSURVIVAL RATEANTI-TOPOISOMERASE IHOSPITALIZATIONOUTCOMECAUSE OF DEATHMYCOBACTERIUM TUBERCULOSISTUBERCULOSISPREGNANCYCLINICAL TRIALS AND METHODSGASTROINTESTINALOUTCOME MEASURESQUALITY OF LIFESCLERODERMA-RELATED DISORDERRHEUMATOID ARTHRITISFORCED VITAL CAPACITYPULMONARY FUNCTION TESTCHRONIC ARTHRITISEARLY ARTHRITISPERIPHERAL ARTHRITISUNDIFFERENTIATED ARTHRITISUNDIFFERENTIATED SPONDYLOARTHROPATHYAGEINGERECTILE DYSFUNCTIONNAILFOLD CAPILLAROSCOPYSCLERODERMA PATTERNVASCULOPATHYCUTANEOUS SCLEROSISRODNAN SKIN SCORESKIN REGRESSIONGENERAL EPIDEMIOLOGY STUDIESMYOSITIS AND RELATED SYNDROMEVASCULITISPERICARDIAL EFFUSIONPERICARDITISPERICARDIUMRAYNAUD'S SYNDROMESCLERODERMA AND RELATED DISORDERTELANGIECTASIALUPUS PSYCHOSISLUPUS VASCULITISNEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (NPSLE)PSYCHOTIC DISORDERSMORTALITY RATEPROGNOSISPULMONARY FIBROSISD-DIMERAZATHIOPRINEIMMUNOSUPPRESSIVE AGENTPOSTERIOR LEUKOENCEPHALOPATHYSEIZUREWHITE MATTER LESIONANTI-SCL70BODY MASS INDEXHYPERTENSIONIDFMETABOLIC SYNDROMENCEP ATP IIIWAIST CIRCUMFERENCEWHOREFERSYSTEMIC SCLEROSIS (SSC)DIAGNOSTIC IMAGINGECHOCARDIOGRAMINCIDENCEPYOGENIC ARTHRITISANTICENTROMERE ANTIBODIESANTITOPOISOMERASE I ANTIBODIESLENGTH OF STAYCLINICAL FEATURESNEUROPSYCHIATRICPREDICTIVE FACTORSARTHRITISAVASCULAR NECROSISOSTEONECROSISINCIDENCE RATEINFECTIONOPPORTUNISTIC INFECTIONLUPUSADENOSINE DEAMINASESYNOVIAL FLUIDTUBERCULOUS SEPTIC ARTHRITISDISSEMINATED TUBERCULOSISTUBERCULOUS ARTHRITISDISEASESFETAL DEATHFETAL GROWTH RETARDATIONINFANTLUPUS ERYTHEMATOSUSNEWBORNPOSTPARTUM PERIODPRE-ECLAMPSIAPREGNANCY OUTCOMESYSTEMICINTER-OBSERVER VARIABILITYINTRA-OBSERVER VARIABILITYVALIDATIONCARDIOVASCULAREPIDEMIOLOGYFIBROBLASTLABORATORY DIAGNOSISOVERLAP SYNDROMESCLERODERMA–POLYMYOSITIS OVERLAPSELF-ASSESSMENT SKIN TIGHTNESSPHOTOTHERAPYTREATMENT OUTCOMEULTRAVIOLET ACARDIO-ANKLE VASCULAR INDEXPERIPHERAL ARTERIAL STIFFNESSDIAGNOSISEVIDENCE-BASED RECOMMENDATIONREFERRALTREATMENTCLINICAL ASPECTS SYSTEMIC SCLEROSISEPIDEMIOLOGY SYSTEMIC SCLEROSISELDERLY-ONSETBOSENTANLUNG FIBROSISOSTEOPOROSISZOLEDRONIC ACIDDMARDSOBSERVATIONAL STUDYPERITONEAL DIALYSISRENAL CRISISESOPHAGEAL DILATATIONHIGH RESOLUTION COMPUTED TOMOGRAPHYINTERSTITIAL LUNG DISEASEMEDIASTINAL ADENOPATHYPULMONARY MANIFESTATIONCARDIAC MRIMYOCARDIAL FIBROSISMYOCARDIAL INFLAMMATIONMYOCARDITISGLOMERULAR DISEASERENAL BIOPSYSCLERODERMA RENAL CRISISADMISSIONEPIDEMIOLOGY STUDYSEASONINTRAUTERINE GROWTH RETARDATIONOUTCOMESPRETERMHYDROGEN BREATH TEST

0.015258550643920898